|
论文编号: |
|
第一作者所在部门: |
|
中文论文题目: |
Noninvasive amide proton transfer magnetic resonance imaging in evaluating the grading and cellularity of gliomas
|
英文论文题目: |
Noninvasive amide proton transfer magnetic resonance imaging in evaluating the grading and cellularity of gliomas
|
论文题目英文: |
|
作者: |
Bai, Yan
|
论文出处: |
|
刊物名称: |
ONCOTARGET
|
年: |
2017
|
卷: |
8 |
期: |
4 |
页: |
5834-5842 |
联系作者: |
|
收录类别: |
|
影响因子: |
|
摘要: |
Using noninvasive magnetic resonance imaging techniques to accurately evaluate the grading and cellularity of gliomas is beneficial for improving the patient outcomes. Amide proton transfer imaging is a noninvasive molecular magnetic resonance imaging technique based on chemical exchange saturation transfer mechanism that detects endogenous mobile proteins and peptides in biological tissues. Between August 2012 and November 2015, a total number of 44 patients with pathologically proven gliomas were included in this study. We compared the capability of amide proton transfer magnetic resonance imaging with that of noninvasive diffusion-weighted imaging and noninvasive 3-dimensional pseudo-continuous arterial spin imaging in evaluating the grading and cellularity of gliomas. Our results reveal that amide proton transfer magnetic resonance imaging is a superior imaging technique to diffusion-weighted imaging and 3-dimensional pseudo-continuous arterial spin imaging in the grading of gliomas. In addition, our results showed that the Ki-67 index correlated better with the amide proton transfer-weighted signal intensity than with the apparent diffusion coefficient value or the cerebral blood flow value in the gliomas. Amide proton transfer magnetic resonance imaging is a promising method for predicting the grading and cellularity of gliomas. |
英文摘要: |
|
外单位作者单位: |
|
备注: |
|
关闭窗口 |
|